Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.61 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6012893 | 0.90 | CCR5 (0.98) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| Hydrochloric Acid SCHEMBL5611798 | 0.90 | CCR5 (1.00) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| SCHEMBL6012956 | 0.87 | CCR5 (0.89) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| SCHEMBL6013026 | 0.87 | CCR5 (0.82) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| SCHEMBL6012591 | 0.86 | CCR5 (0.82) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| Hydrochloric Acid SCHEMBL5612361 | 0.86 | CCR5 (0.91) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| SCHEMBL6012474 | 0.86 | CCR5 (0.90) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| Hydrochloric Acid SCHEMBL5612733 | 0.86 | CCR5 (0.84) | CCR5CYP3A4CYP2D6CYP2C9CHRM3 | |
| SCHEMBL6012988 | 0.84 | CCR5 (0.80) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 | |
| SCHEMBL6012630 | 0.83 | CCR5 (0.84) | CCR5CYP3A4CYP2D6CYP2C9CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7119091-B2 | Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-10-10 | — | — | US | claimed |
| EP-1236726-B1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-12-01 | — | — | EP | claimed |
| EP-1236726-A1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-09-04 | — | — | EP | claimed |
| US-7285552-B2 | Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient | ONO PHARMACEUTICALS CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7285552-B2 | Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient | ONO PHARMACEUTICALS CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| EP-1236726-B1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO (JP) | 2004-12-01 | — | — | EP | disclosed |
| EP-1378509-A1 | DRUGS CONTAINING TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-01-07 | — | — | EP | disclosed |
| EP-1236726-A1 | TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-09-04 | — | — | EP | disclosed |